Loss of Glut1 accelerated neutrophil turnover in tumors, diminishing a SiglecF-expressing neutrophils subset, thereby inhibiting tumor growth and enhancing the effectiveness of radiotherapy 174. The gene discussed is SLC2A1; the disease is neoplasm.